What’s Next in Long-Acting Insulin Therapy?
Stay at the forefront of diabetes care with ATTD Diabetes Talks: Long-Acting Insulin Uncovered — a new ATTD podcast series designed for healthcare professionals who want real-world insights, expert guidance, and actionable knowledge on long-acting insulin therapy.
New episode every Tuesday!
🎧 About the Podcast
Hosted by diabetes advocate and author Ginger Vieira and powered by ATTD, this series features conversations with top experts — from CDCESs and PharmDs to pediatric endocrinologists and individuals living with diabetes.
Each episode will dive deep into:
- The latest trends in long-acting insulin therapy
- Clinical applications and patient outcomes
- Strategies for patient selection and engagement
- Real-world stories and lessons from the field
🎙️ Episode 1: Introduction to Long-Acting Insulin Therapy
Special Guest: Jennifer Okemah, RD, CDCES
With nearly two decades of experience as a Registered Dietitian and Certified Diabetes Care and Education Specialist, Jennifer brings expert insights into how long-acting insulin has evolved — and how it’s making a real difference for patients and clinicians alike.
Learning Outcomes:
- Develop a thorough comprehension of long-acting insulin therapy.
- Recognize the benefits and role of long-acting insulin in diabetes management.
- Understand the evolving landscape of long-acting insulin therapies.
🎙️ Episode 2: Understanding the Benefits of Long-Acting Insulin
Special Guest: Dr. Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES
Diana Isaacs is a diabetes advocate and the Director of Education & Training in Diabetes Technology at the Cleveland Clinic. She is also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinical Pharmacy (FCCP).
Learning Outcomes:
- Understand the pharmacokinetics and pharmacodynamics of long-acting insulin.
- Learn how long-acting insulin improves blood glucose control and reduces injection burden.
- Explore emerging once-weekly insulin formulations and their impact on care.
🎙️ Episode 3: Patient Selection Criteria for Long-Acting Insulin Therapy
Special Guest: Dr. Ladan Davallow
Ladan Davallow is a Pediatric Endocrinologist and Type 1 Diabetes Consultant at the Medical University of South Carolina. She is also the co-founder of EndoMD Health, a Virtual Pediatric Endocrine Care Practice.
Learning Outcomes:
- Identify key factors influencing patient selection for long-acting insulin therapy.
- Evaluate the role of insulin resistance, lifestyle, and treatment goals in therapy decisions.
- Apply real-world examples to inform clinical decisions in diabetes care.
🎙️ Episode 4: Initiating, Titrating, and Monitoring Long-Acting Insulin
Special Guest: Aimee Jose, RD, CDCES
Aimée José is the Principal Clinical Educator at Codex Health. She is a skilled Diabetes Educator with extensive expertise in clinical diabetes care and technology.
Learning Outcomes:
- Understand key factors in initiating, titrating, and monitoring long-acting insulin.
- Learn step-by-step guidance on dose titration, adjustments, and managing side effects.
- Explore strategies for patient education and improving patient-provider collaboration.
🎙️ Episode 5: Integrating Long-Acting Insulin with Other Therapies
Special Guest: Dr. Egils Bogdanovics
We discuss combining long-acting insulin with mealtime insulin, oral medications, and GLP-1 receptor agonists, the role of lifestyle modifications in optimizing insulin effectiveness, and the use of CGM data to refine insulin therapy.
Learning Outcomes:
- Combine long-acting insulin with other diabetes treatments effectively
- Use lifestyle strategies to optimize insulin therapy
- Apply CGM data to fine-tune insulin dosing and improve outcomes
🎙️ Episode 6: Updates and Emerging Trends in Long-Acting Insulin Therapy
Special Guest:
Lucia M. Novak, MSN, ANP-BC, BC-ADM
Discussing the latest in long-acting insulin therapy, including new formulations, smart delivery technologies, GLP-1/GIP therapies, and strategies to reduce treatment burden and improve quality of life for people with diabetes.
Learning Outcomes:
- Highlight recent updates in long-acting insulin therapy
- Explain emerging insulin formulations and delivery technologies
- Recognize strategies to ease treatment burden and enhance quality of life
🎙️ Episode 7: Real-World Applications and Success Stories
Special Guests:
Christel Oerum and Real Prince Blue
Ginger Vieira talks with Christel Oerum (T1D) and Real Prince Blue (T2D) about real-world experiences with long-acting insulin, personalized strategies, patient-provider collaboration, and balancing diabetes care with lifestyle.
Learning Outcomes:
- Highlight challenges in real-world insulin therapy
- Explain how personalized strategies and collaboration improve outcomes
- Identify ways to balance diabetes care with lifestyle choices
🎙️ Episode 8: Common Questions Answered; Advancing Long-Acting Insulin in Practice
Special Guests: Dr. David Ahn
In the final episode, we cover challenges in diabetes management, adjusting insulin doses, Time in Tight Range (TITR), fasting, GLP-1 therapy, weekly insulin injections, hypoglycemia risk, personalized approaches, and diabetes care in athletes.
Learning Outcomes:
- Adjust insulin and manage diabetes challenges
- Apply TITR, hypoglycemia, and GLP-1 considerations
- Use personalized strategies for diverse patient populations
Get expert insights, one conversation at a time.
🎙️ Start listening today. Empower your practice tomorrow.
This series is supported by Eli Lilly and Company.